Daily Dose - Jun 24th, 2026
Daily Dose |
View online
June 24, 2026
Lonza sees flurry of ADC technology licensing agreements
In the space of three weeks, the company has announced four separate antibody-drug conjugate deals with AmMax Bio, Antharis Therapeutics, InduPro, and Stipple Bio.
Read More
Shilpa Biologicals commissions ADC drug substance manufacturing facility
The site in Dharwad, India will support integrated development and GMP manufacturing of antibody-drug conjugate drug substances.
Read More
Investment firm buys pharma manufacturing digital platform from Applied Materials
The platform combines real-time analytics and AI-based process intelligence to support biopharma and life sciences manufacturing operations.
Read More